The ABFA team has achieved Remarkable R&D accomplishments in the environmental sector,and also demonstrated robust expansion capabilities within the medical field. Targeting the prevention and treatment of critical clinical infectious diseases as well as hospital-acquired infection control,the company innovatively involves in the application of new material technologies for pathogen adsorption and filtration.
By integrating world-leading biomedical research methodologies and collaborating with large-scale hospitals, ABFA is developing a full range of innovative terminal products for the prevention and control of multiple pathogenic microorganisms, which outperform existing mainstream technologies.